Royal Bank of Canada’s Putnam BioRevolution ETF SYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Sell |
1,516
-592
| -28% | -$16.8K | ﹤0.01% | 5618 |
|
|
2025
Q1 | $59K | Sell |
2,108
-2,410
| -53% | -$67.5K | ﹤0.01% | 5138 |
|
|
2024
Q4 | $134K | Sell |
4,518
-390
| -8% | -$11.6K | ﹤0.01% | 4688 |
|
|
2024
Q3 | $162K | Buy |
4,908
+3,919
| +396% | +$129K | ﹤0.01% | 4550 |
|
|
2024
Q2 | $31K | Sell |
989
-329
| -25% | -$10.3K | ﹤0.01% | 5489 |
|
|
2024
Q1 | $41K | Sell |
1,318
-19,639
| -94% | -$611K | ﹤0.01% | 5185 |
|
|
2023
Q4 | $610K | Buy |
20,957
+20,841
| +17,966% | +$607K | ﹤0.01% | 3599 |
|
|
2023
Q3 | $3K | Sell |
116
-7,064
| -98% | -$183K | ﹤0.01% | 6235 |
|
|
2023
Q2 | $199K | Sell |
7,180
-7,885
| -52% | -$219K | ﹤0.01% | 4335 |
|
|
2023
Q1 | $411K | Sell |
15,065
-2,793
| -16% | -$76.2K | ﹤0.01% | 3684 |
|
|
2022
Q4 | $464K | Buy |
+17,858
| New | +$464K | ﹤0.01% | 3735 |
|